Our laboratory had previously demonstrated that the combination of rapamycin and panobinostat resulted in HIF-1α protein degradation associated with a reduction in tumor angiogenesis of prostate and renal cell carcinoma xenograft models [19]. This evidence concerns the gene HIF1A and renal cell carcinoma.